Company: NIVFW
Filing Date: 2025-05-29
Form Type: F-1/A
Source: 0001213900-25-048554
Chunk: 32

Company: NewGenIvf Group Ltd
Filing Date: 2025-05-29
Form: F-1/A
Chunk 32
---
 28, 2025 (the “Hearing”). On February 19, 2025, the Company received written decision from the Panel, which granted an extension, allowing the Company additional time to regain compliance with the Nasdaq Stock Market’s (“Nasdaq” or the “Exchange”) continued listing requirements, subject to meeting specific compliance criteria within designated timeframes. On February 11, 2025, the Company carried out a 1-for-20 reverse stock split of its issued and unissued shares. The effect of the reverse stock split was to consolidate every 20 issued and unissued share into one share. On February 27, 2025, the Company received a notification letter from Nasdaq, indicating that the closing bid price of the Company’s securities had been at $1.00 per share or greater for 10 consecutive business days from February 11, 2025 to February 26, 2025, and the Company had regained compliance with the minimum bid price rule. In addition, on February 27, 2025, the Company received a confirmation from Nasdaq that its application to transfer its listing to the Nasdaq Capital Market had been approved and that the Company’s securities would be transferred to the Nasdaq Capital Market at the opening of business on February 28, 2025. 18

Capitalization and Indebtedness Below is the Company’s capitalization and indebtedness as of December 31, 2024:

|                            |     | US$ |          |   |
| Cash and Cash equivalents  |     |     |  457,740 |   |
| EQUITY AND LIABILITIES     |     |     |          |   |
| Share capital              |     |     |        0 |   |
| Subscription receivable    |     |     | (204,000 | ) |
| Additional paid-in capital |     |     |  122,505 |   |
| Accumulated deficit        |     |     | (985,994 | ) |
| Total capitalization       |     |     | (609,749 | ) |

|                          |     | As of        
 December 31, 
 2024         |            |   |
|:-------------------------|:----|:-------------|-----------:|:--|
|                          |     | US$          |            |   |
| Total Net Book Value     |     |              | (1,481,757 | ) |
| Total Share Outstanding* |     |